New Study Provides Information on the Impact of CBD on Consumer’s Health
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more…
Browsing: Federal
The American Hospital Association Calls for Action on Prior Authorizations in Medicare Advantage Plans
On May 19, 2022, the American Hospital Association (AHA) sent a letter to the Administrator…
CCSS Sends Letter of Support for Dietary Supplement Listing Act of 2022
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to…
Aimed Alliance summarizes Johnson & Johnson’s lawsuit against SaveOnSP
On May 4, 2022, Johnson & Johnson filed a complaint in the United States District…
Aimed Alliance adds FAQ to Copay Accumulator 101 Hub
On May 15, 2022, Aimed Alliance updated its Copay Accumulator 101 Hub to include a…
Aimed Alliance Releases New Maps on Biomarker Testing
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted…
FDA Asks Congress for New Authority To Regulate CBD
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol…
The White House and Federal Agencies Focus on Addressing Long COVID
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed…
Aimed Alliance Speaks at HealthyWomen’s Cures 2.0 Virtual Policy Discussion
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on…
AHIP Pushes Back on HHS Efforts To Ensure Non-Discrimination in Plan Design
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S.…